1. Fambrough DM, Drachman DB, Satymurti S. Neuromuscular function in myasthenia gravis: decreased acetylcholine receptors. Science. 1973;182:293–5.
2. De Aizpurua HJ, Lambert EH, Griesmann GE, Olivera M, Lennon VA. Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies omega-conotoxin and adenosine. Cancer Res. 1988;48:4719–24.
3. Howard JF. Adverse drug interactions in disorders of neuromuscular transmission. J Neurol Orthop Med Surg. 1991;12:26–34.
4. Barrons RW. Drug-induced neuromuscular blockade and myasthenia gravis. Pharmacotherapy. 1997;17:1220–32.
5. Nieman RB, Sharma K, Edelberg H, Caffe SE. Telithromycin and myasthenia gravis. Clin Infect Dis. 2003;37:1579.